Skip to main content
. 2022 May 12;16:1387. doi: 10.3332/ecancer.2022.1387

Table 2. Most common adverse events (>5%) reported by patients treated with adjuvant chemotherapy (n = 85).

Adverse events All grades Grade 1 or 2 Grade 3 or 4
Neutropenia 36 (42.4%) 21 (24.7%) 15 (17.7%)
Nausea 34 (40%) 34 (40%) 0
Peripheral neuropathy 30 (35.3%) 29 (34.1%) 1 (1.2%)
Diarrhoea 27 (31.8%) 27 (31.8%) 0
Asthenia 11 (12.9%) 11 (12.9%) 0
Hand–foot syndrome 9 (10.6%) 9 (10.6%) 0
Thrombocytopenia 6 (7%) 5(5.8%) 1 (1.2%)
Anaemia 6 (7.1%) 6 (7.1%) 0